
Alphabet Inc.'s (NASDAQ:GOOG) (NASDAQ:GOOGL) Isomorphic Labs says its first artificial-intelligence-designed medicines are nearly ready for human testing.
What Happened: Isomorphic Labs President Colin Murdoch spoke to Fortune in an interview recently where he said, “There are people sitting in our office in King's Cross, London, collaborating with AI to design drugs for cancer right now.”